RxDoctor Payments Data

Alexzondra Greco

Family · Metairie, LANPI 1013761626

Payments from drug & device makers

$275in general payments, 2019–2025

Across 14 payments — averaging $19.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$54
  • E.r. Squibb & Sons, L.L.C.$39
  • Pfizer$31
  • Otsuka America Pharmaceutical, Inc.$30
  • Merck$23
  • Cipher Pharmaceuticals US LLC$19
  • plus $79 from 5 others

What the payments were for

  • Food & beverage$275100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$275 in reported general payments places this provider in the 35th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Medicare billing

Part B allowed, 2024
$3,639
Medicare patients
12
Services billed
45

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl18$439
Fluticasone Propionate19$185

Paid to pharmacies, not to this prescriber.

Other family in Metairie

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →